Atreca, Inc.

Atreca, Inc.verified

BCEL

Price:

$0.09

Market Cap:

$3.57M

Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It also developing APN-122597, a receptor tyrosine kinase that target tumor tissues; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria...[Read more]

Industry

Biotechnology

IPO Date

2019-06-20

Stock Exchange

NASDAQ

Ticker

BCEL

The Enterprise Value as of November 2024 (TTM) for Atreca, Inc. (BCEL) is -8620212.00

According to Atreca, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -8620212.00. This represents a change of -116.95% compared to the average of 50.85M of the last 4 quarters.

Atreca, Inc. (BCEL) Historical Enterprise Value (quarterly & annually)

How has BCEL Enterprise Value performed in the past?

The mean historical Enterprise Value of Atreca, Inc. over the last ten years is 99.85M. The current -8620212.00 Enterprise Value has changed -963.30% with respect to the historical average. Over the past ten years (40 quarters), BCEL's Enterprise Value was at its highest in in the December 2020 quarter at 532.87M. The Enterprise Value was at its lowest in in the June 2019 quarter at -70302524.90.

Quarterly (TTM)
Annual

Average

99.85M

Median

47.93M

Minimum

-56087665.10

Maximum

454.80M

Atreca, Inc. (BCEL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Atreca, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 422.43%

Maximum Annual Enterprise Value = 454.80M

Minimum Annual Increase = -275.84%

Minimum Annual Enterprise Value = -56087665.10

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202263.97M265.97%
202117.48M-96.16%
2020454.80M422.43%
201987.05M-255.21%
2018-56087665.10-275.84%

Atreca, Inc. (BCEL) Average Enterprise Value

How has BCEL Enterprise Value performed in the past?

The current Enterprise Value of Atreca, Inc. (BCEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

178.75M

5-year avg

113.44M

10-year avg

99.85M

Atreca, Inc. (BCEL) Enterprise Value vs. Peers

How is BCEL’s Enterprise Value compared to its peers?

Atreca, Inc.’s Enterprise Value is less than Passage Bio, Inc. (24.72M), greater than Homology Medicines, Inc. (-103303255.00), less than Stoke Therapeutics, Inc. (457.69M), less than TCR2 Therapeutics Inc. (79.12M), less than Revolution Medicines, Inc. (9.43B), less than Black Diamond Therapeutics, Inc. (139.97M), less than Harpoon Therapeutics, Inc. (861.85M), less than Alector, Inc. (383.33M),

Build a custom stock screener for Atreca, Inc. (BCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atreca, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atreca, Inc. (BCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atreca, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Atreca, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Atreca, Inc. (BCEL)?

What is the 3-year average Enterprise Value for Atreca, Inc. (BCEL)?

What is the 5-year average Enterprise Value for Atreca, Inc. (BCEL)?

How does the current Enterprise Value for Atreca, Inc. (BCEL) compare to its historical average?